Skip to content
GLP-1 Scorecard
Menu
Site position #337

MyStart Health

Published by GLP-1 ScorecardUpdated

MyStart Health offers all-inclusive compounded semaglutide and tirzepatide at $299/month with a price-lock guarantee, same-day physician consultations, and 24/7 care team access.

Visit MyStart HealthWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$299/mo (all doses, compounded)
Tirzepatide
$299/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh MyStart Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value48/100
Dose & formulation83/100
Clinical oversight55/100
Labs & monitoring66/100
Fulfillment78/100
Contract terms31/100

Strengths

  • Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

What to consider

  • Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
  • Very new company (incorporated May 2024) with a limited track record
  • FDA issued Matthew Stern, CEO MyStart Health LLC. a warning letter in September 2025; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want fastest compounded GLP-1 onboarding with a price lock.

Site position #337 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Matthew Stern, CEO MyStart Health LLC. in September 2025. See the FDA warning-letter database.

Closest here

The rankings grading nearest MyStart Health — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect MyStart Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on MyStart Health's site. Not medical advice; see our disclosure.

← Back to the scorecard